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http://www.biomedcentral.com/1471-2288/13/153RESEARCH ARTICLE Open AccessLessons learnt recruiting to a multi-site UK cohort
study to explore recovery of health and well-being
after colorectal cancer (CREW study)
Deborah Fenlon1, Kim Chivers Seymour1, Ikumi Okamoto1, Jane Winter2, Alison Richardson1,2, Julia Addington-Hall1,
Jessica L Corner1, Peter W Smith1, Christine M May1, Matthew Breckons3 and Claire Foster1*Abstract
Background: The UK leads the world in recruitment of patients to cancer clinical trials, with a six-fold increase
in recruitment during 2001–2010. However, there are large variations across cancer centres. This paper details
recruitment to a large multi-centre prospective cohort study and discusses lessons learnt to enhance recruitment.
Methods: During CREW (ColoREctal Wellbeing) cohort study set up and recruitment, data were systematically
collected on all centres that applied to participate, time from study approval to first participant recruited and the
percentage of eligible patients recruited into the study.
Results: 30 participating NHS cancer centres were selected through an open competition via the cancer networks.
Time from study approval to first participant recruited took a median 124 days (min 53, max 290). Of 1350 eligible
people in the study time frame, 78% (n = 1056) were recruited into the study, varying from 30-100% eligible across
centres. Recruitment of 1056 participants took 17 months.
Conclusion: In partnership with the National Cancer Research Network, this successful study prioritised relationship
building and education. Key points for effective recruitment: pre-screening and selection of centres; nurses as PIs;
attendance at study days; frequent communication and a reduced level of consent to enhance uptake amongst
underrepresented groups.
Keywords: Cohort, Colorectal cancer, Health and wellbeing, Study processes, RecruitmentBackground
Recruitment of participants with cancer from clinical
settings into research studies is commonly reported as
slow and only a minority reach their original recruitment
target [1]. The lack of agreement between expected and
achieved targets for recruitment has major implications
for study outcomes and the allocation of scarce resources.
Studies take longer than planned and effort required to
recruit hard to reach groups means they are likely to
remain underrepresented, leading to bias in published
research. In the United Kingdom, national support systems
and infrastructure, such as the National Cancer Research
Network (NCRN), part of the National Institute for Health* Correspondence: C.L.Foster@soton.ac.uk
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1BJ, UK
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reproduction in any medium, provided the orResearch (NIHR) Clinical Research Network (CRN) have
been introduced with great success to increase the number
of patients participating in clinical research studies,
with the result that the UK leads the world in recruiting
to cancer clinical trials [2]. Since the NCRN was established
in 2001 recruitment rates to clinical research cancer
trials have increased steadily, first quadrupling [3] and
now rising to six fold, with an increase of 3.5% to 23%
of all incident cancer cases [4] and 75% of studies meeting
the recruitment target, compared with 39% before the
NCRN was established [5]. A key feature of this success is
the use of dedicated research nurses to recruit to portfolio
studies. More recently, the UK government announced
incentives for initiation and delivery in research in 2011
[6]. The NIHR developed the Research Support Services
Framework in 2011 that required NHS service providers
to publish outcomes against contract NIHR benchmarksLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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should be 70 days or less from the time a provider of
NHS services receives a valid research application to
the time when that provider recruits the first patient for
that study [7]. Nevertheless, there remain large variations
between the ability of individual cancer centres to recruit
to research. Patterson et al. [8] suggest that effective
negotiation of ‘gatekeeping’ with those who mediate
access to potential participants is vital to the process
and outcomes of trials and the quality of evidence.
They conceptualise successful recruitment as a process
consisting of three phases: set up, alliance and exchange,
where each phase is dependent on satisfactory negotiation
of the other. We utilise their framework to describe the
experience of recruiting a large cancer cohort from
multiple sites across Great Britain during 2011/2012.
The study successfully recruited a high percentage of
eligible patients within a short time frame. The processes
that were utilised to enhance recruitment are discussed, as
well as difficulties encountered, and recommendations for
future studies. We also present detailed data that compare
individual recruiting centres including time to obtain
governance approvals, time to recruit and percentage
of eligible patients recruited.
Methods
The CREW (ColoREctal Wellbeing) study is a prospective,
longitudinal cohort study of 1056 colorectal cancer
survivors using a mailed questionnaire survey, aiming
to follow the path of recovery from colorectal cancer
from baseline, prior to surgery, with regular follow-up
questionnaires [9]. Despite participants having just
been diagnosed with cancer we were able to recruit a
very high percentage (78%) of the eligible population for
this study and obtained consent for basic demographic
details for a further 13%, enabling us to have basic details
for 91% of the total cohort. From these data it will be
possible to identify those who are at risk of making a
poor or protracted recovery in order to target resource
appropriately. Recruitment to the study was via NHS
colorectal cancer pre-surgical clinics, with the support
of dedicated research nurses. All those with a diagnosis
of colorectal cancer with no distant metastases (Dukes
A-C) and 18 years or over were eligible for the study.
Prior diagnosis of cancer (other than non-melanomatous
skin cancer or in situ carcinoma cervix) was an exclusion
criterion. A particular challenge for this study was the
need to minimise bias by ensuring that every individual
who met these very broad criteria was approached for
participation in the study and that data were collected
on those who were not recruited. This required recruiting
staff to provide detailed screening logs to the co-ordinating
centre about numbers of people presenting who were
eligible, how many were recruited, how many declinedand how many were missed. Clinical trials often exclude
hard to reach groups, such as the elderly and frail,
however, it was necessary for us to understand the
needs and recovery trajectory of this group and so it
was important to include all groups in the study. It
became clear that some people were electing not to
join the study due to questionnaire burden, and so a
second level of consent was included, whereby routinely
collected data could be accessed at regular intervals and
monitored over time. This constituted a second level of
consent, known as reduced consent.
Recruitment and management of the study
The study was set up and managed by the co-ordinating
centre at the Macmillan Survivorship Research Group,
University of Southampton. A pilot study was undertaken
in 2010 in one centre to test recruitment rates and
procedures. The Principal Investigator at this site was
the colorectal cancer consultant nurse. Eligible patients
were identified by the nurse specialist team and logged
prior to primary surgery at a multi-disciplinary team
(MDT) meeting. Eligible patients were informed about
the study by their clinicians (either their surgeon or
clinical nurse specialist) and by written information,
and recruited at a pre-surgical assessment clinic by the
nurse practitioner. The nurse practitioner took consent
and provided participants with the baseline questionnaire.
Information was supplied to the co-ordinating centre on
all eligible patients and outcomes recorded as ‘missed’,
‘recruited’, ‘refused’, with reasons given for ‘missed’ and
‘refused’. Demographic details were taken with consent
from those who declined entry to the study. All subsequent
questionnaires were sent directly from the co-ordinating
centre. Following the pilot the reduced level of consent
was introduced to enable the collection of clinical data
about those who found questionnaire completion a
burden.
The study protocol and measures have been previously
published [9]. The study was sponsored by the University
Hospital Southampton NHS Foundation Trust Research
and Development Office (R&D number: RHM CAN0737)
and ethical approval was given through the Oxfordshire
REC B National Research Ethics Committee (REC reference
number: 10/H0605/31).
Set up: Identify and contact
The first process in Patterson et al’s [8] framework is to
identify and make contact with the various gate keepers
which must be negotiated to gain access to the target
population. They suggest the most effective way to do this
is by face to face contact and the use of multiple communi-
cation channels; with the maintenance of good relationships
in these early tasks being key. These relationships were
not already in place prior to this study which would have
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work was done to create these relationships. As this
was a large, national study involving 30 cancer centres,
the opportunities for personal and face to face contact
were limited, so we selected a method by which centres
opted in to the study, rather than being approached.
The study was submitted to and adopted by the National
Cancer Research Institute Clinical Studies Group for
Colorectal Cancer. An invitation was sent via the NCRN
to all cancer network research managers to submit an
Expression of Interest to participate in the study. The
criteria used for selection of participating centres were
set to enhance the chance of both rapid recruitment
and also recruitment of a high percentage of eligible
people. These included: a single point where all patients
with colorectal cancer could be identified and screened
(this was normally a MDT) and for an identified person
to be present to identify every eligible patient; one key
clinic prior to surgery where every eligible patient could
be approached; no competition with other studies; at least
one staff member available for the training day; the ability
to recruit at a rate of two to three participants a week;
local research governance procedures to be completed
within six weeks. Other factors taken into consideration
when selecting centres were to cover varied socio-
demographic and geographical locations. Selected centres
were contacted by phone, including conference calls,
and email and careful work done through these com-
munications to set up good relationships. Identification
and approach of eligible patients would normally be by
dedicated research nurses, supported by the NCRN,
although this was not a requirement.
Alliance: connect and engage
Connecting is described by Patterson et al. [8] as engaging
the hearts and minds of the gatekeepers, by establishing
common ground, in order to develop a shared goal and
for the gatekeeper to become an ally in the recruitment
process. As the underlying principles of this piece of
research were about recovery and psychosocial wellbeing
it was thought common ground was more likely to be
established with local nursing staff and these became the
prime focus of our engagement. We suggested that it
would be appropriate for clinical nurse specialists or lead
research nurses to be local Principal Investigators which
would give them more authority and a vested interest in
promoting and undertaking effective research.
Engagement is interactive and intellectual, depending
on research credibility, demonstrated through reasoned
and critical discussion of the evidence-based approach
and study methods [8]. Once the pilot was complete a
training day was held for Principal Investigators and
research nurses. Travel and accommodation were paid for
recruiting centre staff to attend. This face to face day wasessential to establish a trusting relationship between the
researchers and staff at the participating centres. The
study design, purpose and methods were described, for
example, stressing the importance of inviting ALL eligible
people to participate in CREW, in order to avoid bias,
allowing time for a sharing of knowledge and processes
between centres. Studies conducted through the NCRN
are typically randomised controlled trials, therefore the
understanding of observational cohort studies was limited
and education focussed on the need to understand the
cohort as a whole. People who had had cancer were
involved in all these training days, so that they could share
from their perspective why the study was important and
to support the research nurses in recruitment issues. The
research nurses rehearsed recruitment and other study
procedures, which varied slightly at each centre. Two
further training days were held as these were found to be
the most effective way of enabling engagement. Following
the training, a teleconference was conducted with each
individual site to initiate the study. Ongoing support from
the co-ordinating centre took the form of continued
frequent email and telephone communications between
the centres and the lead researcher or study adminis-
trator throughout the set-up and recruitment period to
provide updates and address set-up and recruitment
queries promptly.
Exchange: request and resolve
Once a shared goal is established the researcher frames
requests to fit with the goal and resolution is reached with
an overt agreement about further contact, which is mutu-
ally respectful [8]. Gatekeepers require specific, achievable
and realistic requests with clear time boundaries. Partici-
pating centres were requested to send weekly updates on
recruitment status. In order to clarify and simplify what
was required of participating centres, a central administra-
tor provided clear requests for any outstanding informa-
tion. To maintain engagement, a monthly newsletter was
distributed to centres to update them on progress and to
share best practice. A website was also developed for the
recruiting nurses to share best practice. The third study
day was held near the end of recruitment and recruiters
were able to feed into the process of data gathering and
sharing. Detailed evaluation was gathered at this event
on issues around the conduct of the study, difficulties
encountered and potential solutions shared. This was also
used as a celebration of successful recruitment which
enhanced the sense of a shared goal and set the scene
for future effective collaborations.
Results
Selection of participating sites
After the initial invitation, 49 centres submitted an Expres-
sion of Interest through the NCRN, from which 21 plus
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and Northern Ireland (not in the NCRN) were approached
directly and two were selected. All centres met the selection
criteria. Evidence of a close working and committed team
(surgeons, research nurses and clinical nurse specialists)
and a track record of recruitment to previous studies
were taken into consideration. Participating centres were
informed of selection in December 2010 and expected
to start recruiting in February 2011, following the study
set-up training day in January. In May 2011, not all centres
had begun recruitment and the overall recruitment rate
was slower than expected. The decision was therefore
taken to increase the number of recruiting centres to
ensure recruitment targets were met within the allocated
time frame and a further six centres were selected. One
of the selected centres failed to screen or recruit eligible
patients and was therefore excluded from analysis and
study reporting. Ultimately 29 centres actively contributed
to recruitment of participants. Time taken to conduct
the study from initial approvals to achieving target
recruitment is shown in Figure 1. Patient recruitment flow
from numbers eligible to participate to numbers consented
to study is shown in Figure 2. Each centre has been pre-
sented with the opportunity to verify the data in this paper.
Attendance at training days
The initial study set up training day was attended by 29
people from 17 centres. Six centres failed to send anyoneFigure 1 Time taken to conduct study from initial approvals to achievdespite prior notice and this being a condition for selection.
The other six centres were selected following this initial
training day. This training day was useful to engage in
mutually respectful exchange of knowledge and enabled us
to confirm and consolidate our communication processes
with the participating centres. For example, centres indi-
cated that they would like: information on total recruitment
to the study and how they compared to other centres;
regular newsletters with updates; helpful tips about
the study and how to share best practice and that
email was the preferred form of communication. All
of these were acted upon and put into place. The sec-
ond training day was attended by 21 people from 16
centres. This day was intended to be a set up training
day for the newly selected centres (four out of six
attended) but many other centres took the opportunity
to be updated on the study and to resolve issues that
had arisen during recruitment. Feedback from this day
that was acted upon included: building the website for
research nurses to share best practice and the prepar-
ation of a set of slides for the nurses to present to their
MDTs in order to enhance engagement at the local
sites. The final day was at the completion of recruit-
ment and was attended by 20 people from 14 centres.
The opportunity was taken at this time to discuss what
had been difficult about the study processes and to
consider how these procedures could be improved in
the future.ing target recruitment.
Figure 2 Patient recruitment flow from numbers eligible to participate to numbers consented to study.
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The total time from study approval in the leading NHS
site to recruitment close across all sites was 23 months.
This included six months for sponsorship, ethical approval
(following revision), portfolio adoption, local cancer services
directorate approval and local R&D approval (Table 1).
The median number of days from a site being selected
to recruiting the first participant into the study was 124 days
(range 53–290) (see Table 1). This included research
approval, local set up, screening participants to first
participant consented. There is now a national target in
place for this to take place within 70 days. In this study
only 6 centres completed these processes within 70 days.
The time taken from a centre being informed that they
had been selected to obtaining local research approvalvaried from 13 to 180 days (median 63). Breaking this
figure down further, from site selection to research
submission ranged from 0 to 145 days (median 30)
and from research submission to approval took 0 to
146 days (median 35). Once research approval had been
obtained, the time taken to give permission to open the
study took from 0 to 49 days (median 3). This delay
was due to staff holidays and delays in the coordinating
centre being informed that local research approval had
been granted. The time taken from the co-ordinating
centre giving permission to open the study to the date
of first screening by the MDT ranged from 0 to 136 days
(median 15) and then from screening to the first patient
recruited by a centre was 0 to 55 days (median 10). These
data per recruiting centre are given in Table 1. Several
Table 1 Time (days) taken per centre to commence recruitment, including research approvals, time to screen for eligible patients and time to first recruit
(in ascending order according to the total time to recruit)
Centre Site selection to
research approvals
submission
Research
submission to
research approval
Total time from
site selection to
research approval
Research approval
to coordinating
centre permission
Coordinating centre
permission to
1st screening
1st screen to 1st
patient recruited
Research approval to
1st patient recruited
Total site selection
to 1st recruit
C 13 35 48 5 0 0 5 53
BB 0 42 42 0 0 17 17 59
B 13 23 36 0 10 15 25 61
D 26 20 46 8 6 7 21 67
E 49 0 49 0 11 12 23 72
F Data not available 63 3 4 4 11 74
G 25 16 41 12 10 12 34 75
H 35 0 35 0 48 0 48 83
I 35 28 63 0 27 0 27 90
J 22 32 54 15 15 7 37 91
K 15 49 64 10 17 0 27 91
L 54 9 63 26 6 0 32 95
M 29 40 69 12 29 1 42 111
N 42 55 97 13 7 2 22 119
O 21 56 77 6 36 5 47 124
P 31 26 57 6 8 55 69 126
Q 35 22 57 3 57 9 69 126
R 48 40 88 37 6 13 56 144
S Data not available 112 0 8 40 48 160
T Data not available 13 0 135 19 154 167
U 62 50 112 0 29 31 60 172
V 0 45 45 49 71 10 130 175
W 145 2 147 0 11 21 32 179
X 34 146 180 5 3 0 8 188
Y 29 89 118 0 61 15 76 194
Z 137 35 172 0 28 6 34 206
AA 28 64 92 0 116 15 131 223
A 21 56 77 4 136 14 154 231
CC 145 2 147 0 129 14 143 290
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Table 1 Time (days) taken per centre to commence recruitment, including research approvals, time to screen for eligible patients and time to first recruit
(in ascending order according to the total time to recruit) (Continued)
Median 30 35 63 3 15 10 37 124
Max 145 146 180 49 136 55 154 290
Min 0 0 13 0 0 0 5 53
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opened at their site to when they started to actively recruit
to the study. These were due to staffing issues, such as sick
leave and change of staff.
Recruitment rates
It took 17 recruitment months to reach the final sample
of 1056 participants with a mean recruitment rate per
centre of 0.71 participants per week (Table 2). Predicted
recruitment time was 12 months, plus two months for
the pilot. Over the period of time that the participating
centres were recruiting, 1350 people were screened as
being eligible for the study. Ninety one per cent of these
were approached about participating in the study (9%
missed); of whom 910 (67% of total eligible) gave full
consent to study participation. A further 146 (11%) gave
consent at the reduced level for their routinely collected
data to be used, without questionnaire completion, and
177 (13%) declined to participate (see Table 2). Following
surgery, 34 participants who had given full consent were
found to be ineligible due to Duke’s stage, metastases or
cancer misdiagnosis. These have been removed from
analysis giving a total cohort of 1022. Basic demographic
data, including gender, age, ethnicity, relationship status,
employment status and postcode (as a measure of social
deprivation), were collected on decliners. The participants
recruited to the study were significantly younger and more
likely to be in employment than those who declined or
gave reduced consent. However, large numbers of older
people gave full consent to the study, with 48% of the total
sample being over 70 years of age and 15% over 80. Older
people were more likely to give reduced consent, which
ensured that we were able to collect data on them. Overall
91% of people aged under 70 and 86% people aged over 70
gave either full or reduced consent to the study.
The most effective recruiting centres were those who
not only recruited large numbers of people into the study,
but also recruited a high percentage of the eligible people,
thus ensuring a representative sample. A Recruitment
Index has been proposed by Rojavin [10] which provides a
measure of the number of days required for an average
study site in a multicentre study to recruit one analysable
participant. However, this measure does not take into
account frequency of screening failure which was important
for this study. We therefore calculated a recruitment
index (RI) for each individual centre as a factor of the
rate of recruitment per centre (the mean number recruited
per week) and the percentage of the people eligible for the
study who were actually recruited (Table 2).
Challenges and strategies to enhance study set up
and recruitment
Data from the final evaluation day suggested three main
areas which affected effective study set up and ongoingrecruitment. These were engagement, ongoing communica-
tion and adequate resourcing.
The first phase of set up [8] involved identifying and
engaging the relevant gate keepers. While we were able
to identify initial gate keepers through the networks, it
became clear that there were a number of gatekeepers in
each organisation and it was important to communicate
with all of these gatekeepers. In this study, this included
research nurses, colorectal cancer clinical nurse specialists,
colorectal cancer surgeons and administrators. It could not
be assumed that there was good internal communication.
One centre reported that the research nurse was the last to
know about the study. Some nurses stated that they found
it difficult to complete the Expression of Interest (EOI)
form. Many of the issues that resulted in poor recruitment
were when centres did not keep to the processes outlined
in the EOI form, particularly having a single MDT meeting
and a single pre-assessment clinic to identity patients. This
could have been reduced if centres had received more help
to complete this initial EOI form and clarification reached
about whether these processes were possible.
Education of and relationship building with participating
site research teams was essential to enable rapid study
set-up. The training days and weekly communications were
the most effective way that this was achieved. However,
connection and engagement with internal gatekeepers was
repeatedly raised as an issue by the research nurses. Once
their commitment was secured, they needed support from
the team at the co-ordinating centre to engage and secure
commitment from other MDT members, particularly the
clinical nurse specialists (CNS) and surgeons. They also
valued the support, where it was available to them, of
administrative staff. Research nurses stated that they did
not have sufficient specialist knowledge to identify eligible
patients and so were dependent on CNSs. They suggested
that the CNSs should have been formally invited to
the initial study training day and that attendance at the
initial training day was a compulsory precondition for
acceptance as a participating centre. The most effective
recruiting centres were those with which we had made
most effective connections and engagement, particularly
where we had made relationships with both the research
nurses and the CNSs. The level of engagement can be
demonstrated by the number of staff that attended our
study days. The total number of staff attending any of our
study days was positively correlated (r = 0.59) with the
Recruitment Index achieved by that centre. Furthermore,
of the five poorest performers, none attended the initial
study day and the top 15 performers all attended the initial
study day.
Nurses appreciated the opportunity to be Principal
Investigators for their site and the fact that this study
was about recovery of wellbeing after cancer meant
that shared values and goals were quickly established.
Table 2 Rate of recruitment per centre, including expected rate, missed, declined and total recruited (in ascending order according to Recruitment Index)
Centre Number
of weeks
recruiting
Expected
recruitment
per week*
Expected total
recruitment
figure**
Total eligible
patients
Missed Declined Reduced
consent
Full
consent
Totals
recruited
% recruited
(total recruited/
total eligible)
Rate
per week
Recruitment
index***
Attended
initial set
up day?
Total number of
nurses attending
study days
BB 80 2 160 217 19 9 24 165 189 87% 2.36 2.06 Yes 4
B 56 3 95 130 6 15 22 87 109 84% 1.95 1.64 Yes 5
L 54 2 104 115 3 10 11 91 102 89% 1.89 1.68 Yes 3
J 56 2 111 94 0 4 7 83 90 96% 1.61 1.55 Yes 5
K 55 1 55 53 1 1 12 39 51 96% 0.93 0.89 Late start 2
CC 26 5 130 25 1 0 5 19 24 96% 0.92 0.88 Yes 3
M 52 2 104 68 7 7 3 51 54 81% 1.06 0.86 Yes 7
W 43 1 43 39 1 2 10 26 36 92% 0.84 0.77 Yes 3
C 60 2 120 52 2 5 12 33 45 87% 0.75 0.65 Yes 3
Z 15 2 31 11 0 1 0 10 10 91% 0.67 0.61 Late start 1
O 51 2 101 57 9 8 8 32 40 70% 0.78 0.55 Yes 3
X 44 3 131 32 6 1 0 25 25 78% 0.57 0.44 Yes 1
Y 42 1 42 28 1 5 2 20 22 79% 0.52 0.41 Yes 4
Q 52 2 111 38 1 9 1 27 28 74% 0.54 0.40 Yes 4
N 46 2 91 41 0 14 4 23 27 66% 0.59 0.39 Late start 2
D 59 2 118 49 3 13 0 33 33 67% 0.56 0.38 Yes 1
A 37 2 73 18 0 2 2 14 16 89% 0.43 0.38 Yes 5
F 38 2 77 47 11 10 7 19 26 55% 0.68 0.37 Late start 2
G 38 2 75 22 3 2 5 12 17 77% 0.45 0.35 No 0
I 55 3 167 52 12 11 5 24 29 56% 0.53 0.30 Yes 4
H 56 1 47 41 4 11 1 25 26 63% 0.46 0.29 Yes 2
V 47 4 187 17 3 3 0 11 11 65% 0.23 0.15 No 1
U 47 2 44 30 7 9 0 14 14 47% 0.30 0.14 Yes 3
E 38 2 76 37 5 20 4 8 12 32% 0.32 0.10 Late start 1
AA 38 2 109 11 2 3 1 5 6 55% 0.16 0.09 No 0
S 35 2 69 3 0 0 0 3 3 100% 0.09 0.09 No 0
R 52 2 103 12 4 1 0 7 7 58% 0.13 0.08 No 0
T 22 2 108 1 0 0 0 1 1 100% 0.05 0.05 No 0
P 34 1 34 10 5 2 0 3 3 30% 0.09 0.03 Late start 1
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Table 2 Rate of recruitment per centre, including expected rate, missed, declined and total recruited (in ascending order according to Recruitment Index)
(Continued)
TOTAL 1350 116 178 146 910 1056 78% 70
9% 13% 11% 67% 78%
*As declared by centre on Expression of Interest and/or Contract (rounded down).
**Number of weeks recruiting x Expected recruitment per week.
***Recruitment Index =mean number recruited per week x percentage of eligible people actually recruited.
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have their views heard; one said ‘Thank you for valuing
our input’. This suggested that we were able to achieve a
mutually respectful relationship.
The exchange phase of the study was also very important
for effective recruitment and required ongoing communica-
tion. The weekly communication included a summary
of all data collected, including all individual study sites
and summary data. We also developed a newsletter for
the participating sites which included ‘frequently asked
questions’ and tips from those centres that had good
recruitment rates. There was a website for the research
nurses with resources available, such as a slide presentation
on the study for research nurses to present to their MDT
members. Positive feedback from the final training day
included comments about easy access to the co-ordinating
centre, rapid feedback to queries, accessibility to the Chief
Investigator when needed, the value of regular feedback,
on recruitment rates, the newsletters and the training
days. Difficulties were a lack of understanding about the
nature of cohort studies and there was a suggestion that
more training days would have been helpful.
Resourcing was an issue at all stages of the process.
Staff absences were a problem; if any key staff member
was absent, this could cause delay to both the set-up and
the recruitment process. There was frequently no cover
provided for research nurse absence, which has a potential
impact of being able to recruit a high percentage of eligible
patients, and research nurses were often overstretched,
needing to cover many different studies, attending clinics
which could be running in parallel or travelling between
different hospital sites (Table 3).
Only one centre, which was the pilot site, achieved the
expected recruitment rates. There are a number of reasons
for this, most of which are organisational issues. Clinicians
generally overestimated the number of eligible patients
attending their centres. This could have been addressedTable 3 Reasons offered for delays in set up and running of t
Problem reported
Sick leave/annual leave
Research nurse overstretched by having to cover many different studies, clin
No single point of access for potential participants (e.g. patients attending fo
could attend any day of the week)
Competing studies. Priority given to clinical trials
PI &/or research nurse unable to engage the rest of the MDT
Research nurse said patients did not want to join study
Research nurse leaving
MDT processes changed since submitting EOI
Contract issues
PI did not have GCP training
Note. PI Principal Investigator, MDT Multidisciplinary team, EOI Expression of Interesin part by a stronger focus on the eligibility criteria for
the study or by asking the sites to monitor eligibility prior
to study entry. Despite initially checking that there were
no conflicting studies, some sites subsequently reported
competing studies and clinical staff were reluctant to
ask patients to participate in more than one study. Drug
studies were likely to be given priority over epidemio-
logical studies.
Discussion and conclusions
This study was successful in recruiting a high percentage
of eligible patients, despite the fact that they had recently
been diagnosed with colorectal cancer. Furthermore, the
period of recruitment was only three months longer than
predicted, despite not having an established relationship
with the recruiting centres prior to the commencement of
the study. The use of a reduced level of consent enabled
the inclusion of a high percentage of older people who are
normally underrepresented in cancer studies.
The use of a theoretical framework helped to enhance
processes of engagement and relationship building, which
had a beneficial impact on effective recruitment. Key
differences in the way that this study was run included
careful pre-screening and selection of participating centres.
Engagement was initiated by inviting centres to submit an
application to join the study, and to commit to a number
of predetermined selection criteria. This is not a routine
method used to select participating centres in UK trials. To
improve this process, further preconditions could be set,
such as minimum recruitment index as well as predicted
recruitment rate. Attendance at the study set up day was
important for communication and education and should
also be a requirement for selection. Enabling nurses at the
recruitment centres to be local Principal Investigator was
unusual and enhanced the sense of personal connection
and engagement with the research, as nurses were largely
responsible for recruitment. Ongoing communication washe study
Number of centres
reporting this problem
8
ics or a number of hospitals 5
r assessment prior to surgery 3
2
2
2
2
1
1
1
t, GCP Good Clinical Practice.
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training was greater than in other UK portfolio studies.
The detailed level of data reported here could be used
for centres to measure performance against, including time
to obtain research governance approvals and recruitment
index. The study as a whole recruited at a median of 0.59
per centre per week (over two per month) and a recruit-
ment index of 0.39 (mean number recruited per week x %
eligible). These figures could be set as targets and be part of
the contractual agreement prior to study commencement.
Recruitment to this study took place in 2010 (including
pilot) until 2012 and successfully recruited 1056 participants
in 17 months. It is noticeable how long it took, and the
degree of variability amongst, study centres to process
their research governance procedures, with a range of
13 to 180 days (median 63). All the participating sites
claimed that they could fulfil local research procedures
within six weeks, but only four centres achieved this.
Since this study has been completed, new targets have
been introduced designed to streamline the research
governance procedures at local centres participating in
UK multi-centre studies, and this aspect of study set up
should now be greatly improved.
The large variations in time to commence recruitment
following permission to start appeared to be largely due to
resource and staffing issues. Full support needs to be given
to the recruiting sites to ensure they understand study
procedures. Clearly, management of the local research
portfolio is a complex issue and the inability to cover staff
absence has major implications for study effectiveness.
There were also large variations between centres in their
effectiveness at recruiting a high percentage of eligible
patients. Addressing the issues at the root of this variation
may enhance recruitment to other studies. Identification
and screening of eligible patients is complex, but could be
enhanced by electronic systems. For high quality research
it is important not just to recruit high numbers, but
that a high percentage of eligible patients are recruited,
in order to reduce bias and ensure representation of the
whole population under study. Recruitment of potentially
vulnerable patients into studies near to primary diagnosis
and undergoing invasive treatment for cancer requires
well trained and supported staff, dedicated to this work.
This is particularly important to reach those who are
typically underrepresented in research, such as the frail,
elderly or with low literacy, and adequate time and support
is needed to enable these people to make appropriate
decisions about research. Clinical systems in many areas,
particularly large cancer centres, are not designed to facili-
tate this. In order for research to be effective and of
high quality, research must be seen as integral to and high
priority for multidisciplinary working, with commitment
from all team members, and adequate resourcing of
research nurses.Working with the NCRN from the outset and inviting
sites from throughout the UK to submit an Expression of
Interest (EOI) was a valuable way to commence recruit-
ment as speedily as possible. One to one discussions about
the EOI could have enhanced the selection process and
initiated development of relationship building with partici-
pating centre. Development of good working relationships
with study sites was essential to the success of this study,
built on frequent and regular contact by phone, email
and face to face. Adequate resourcing of the coordinating
centre was crucial to allow this.
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